Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Racial difference in histologic subtype of renal cell carcinoma.

Olshan AF, Kuo TM, Meyer AM, Nielsen ME, Purdue MP, Rathmell WK.

Cancer Med. 2013 Oct;2(5):744-9. doi: 10.1002/cam4.110. Epub 2013 Aug 6.

2.

Renal cell cancer histological subtype distribution differs by race and sex.

Lipworth L, Morgans AK, Edwards TL, Barocas DA, Chang SS, Herrell SD, Penson DF, Resnick MJ, Smith JA, Clark PE.

BJU Int. 2016 Feb;117(2):260-5. doi: 10.1111/bju.12950. Epub 2015 Jun 2.

3.

Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics.

Chow WH, Shuch B, Linehan WM, Devesa SS.

Cancer. 2013 Jan 15;119(2):388-94. doi: 10.1002/cncr.27690. Epub 2012 Nov 12.

4.

Rate of renal cell carcinoma subtypes in different races.

Sankin A, Cohen J, Wang H, Macchia RJ, Karanikolas N.

Int Braz J Urol. 2011 Jan-Feb;37(1):29-32;discussion 33-4.

5.

Rising incidence of renal cell cancer in the United States.

Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr.

JAMA. 1999 May 5;281(17):1628-31.

PMID:
10235157
6.

A case-control study of reproductive factors and renal cell carcinoma among black and white women in the United States.

Purdue MP, Colt JS, Graubard B, Davis F, Ruterbusch JJ, Digaetano R, Karami S, Wacholder S, Schwartz K, Chow WH.

Cancer Causes Control. 2011 Nov;22(11):1537-44. doi: 10.1007/s10552-011-9830-8. Epub 2011 Aug 25.

7.

Cigarette smoking and renal cell carcinoma risk among black and white Americans: effect modification by hypertension and obesity.

Cote ML, Colt JS, Schwartz KL, Wacholder S, Ruterbusch JJ, Davis F, Purdue M, Graubard BI, Chow WH.

Cancer Epidemiol Biomarkers Prev. 2012 May;21(5):770-9. doi: 10.1158/1055-9965.EPI-11-1109. Epub 2012 Mar 16.

8.

The association between chronic renal failure and renal cell carcinoma may differ between black and white Americans.

Hofmann JN, Schwartz K, Chow WH, Ruterbusch JJ, Shuch BM, Karami S, Rothman N, Wacholder S, Graubard BI, Colt JS, Purdue MP.

Cancer Causes Control. 2013 Jan;24(1):167-74. doi: 10.1007/s10552-012-0102-z. Epub 2012 Nov 21.

9.

Chronic kidney disease and risk of renal cell carcinoma: differences by race.

Hofmann JN, Corley DA, Zhao WK, Colt JS, Shuch B, Chow WH, Purdue MP.

Epidemiology. 2015 Jan;26(1):59-67. doi: 10.1097/EDE.0000000000000205.

10.
11.

International variations and trends in renal cell carcinoma incidence and mortality.

Znaor A, Lortet-Tieulent J, Laversanne M, Jemal A, Bray F.

Eur Urol. 2015 Mar;67(3):519-30. doi: 10.1016/j.eururo.2014.10.002. Epub 2014 Oct 16. Review.

PMID:
25449206
12.

Age-period-cohort analysis of renal cell carcinoma in United States adults.

Tyson MD, Humphreys MR, Parker AS, Thiel DD, Joseph RW, Andrews PE, Castle EP.

Urology. 2013 Jul;82(1):43-7. doi: 10.1016/j.urology.2013.02.065. Epub 2013 May 22.

PMID:
23706585
14.

Racial disparity in incidence patterns and outcome of kidney cancer.

Vaishampayan UN, Do H, Hussain M, Schwartz K.

Urology. 2003 Dec;62(6):1012-7.

PMID:
14665346
15.

Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006.

Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS.

Thyroid. 2011 Feb;21(2):125-34. doi: 10.1089/thy.2010.0021. Epub 2010 Dec 27.

16.

Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.

Groves FD, Linet MS, Travis LB, Devesa SS.

J Natl Cancer Inst. 2000 Aug 2;92(15):1240-51.

PMID:
10922409
17.

Genomic differences between black and white patients implicate a distinct immune response to papillary renal cell carcinoma.

Paulucci DJ, Sfakianos JP, Skanderup AJ, Kan K, Tsao CK, Galsky MD, Hakimi AA, Badani KK.

Oncotarget. 2017 Jan 17;8(3):5196-5205. doi: 10.18632/oncotarget.14122.

18.

The effect of race and gender on the surgical management of the small renal mass.

Kates M, Whalen MJ, Badalato GM, McKiernan JM.

Urol Oncol. 2013 Nov;31(8):1794-9. doi: 10.1016/j.urolonc.2012.05.005. Epub 2012 Jun 9.

PMID:
22687567
19.

Race and sex disparities in the treatment of older patients with T1a renal cell carcinoma: a comorbidity-controlled competing-risks model.

Patel HD, Kates M, Pierorazio PM, Allaf ME.

Urol Oncol. 2014 Jul;32(5):576-83. doi: 10.1016/j.urolonc.2014.01.002. Epub 2014 Mar 12.

20.

Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival.

Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR.

J Urol. 2008 May;179(5):1704-8. doi: 10.1016/j.juro.2008.01.027. Epub 2008 Mar 17.

Supplemental Content

Support Center